EOS imaging Announces Symposium at the Scoliosis Research Society (SRS) Meeting and Course

Donnerstag, 22.09.2016 18:10



PARIS --(BUSINESS WIRE)--

EOS imaging (Paris:EOSI)(Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, hosted a symposium, ‘spineEOS: simulating and planning spine surgery from weight-bearing 3D patient images’, today at the Prague Congress Centre. The 51st Annual Meeting and Course organized by Scoliosis Research Society (SRS) was an opportunity to showcase the latest advancements in the spineEOS 3D simulation and planning application.

Professors Lawrence Lenke (Columbia Orthopaedics, New York, NY), Peter Newton (Rady Children’s Hospital San Diego, CA), Stefan Parent (CHU Sainte-Justine, Montreal, Canada) and Brice Ilharreborde (Hôpital Robert Debré, Paris, France) have been associated with the development and testing of the spineEOS solution over the past year. The symposium was the first opportunity to present the latest version as well as the advantages of 3D planning, retrospective studies and several complex adults and pediatric case studies.

Marie Meynadier, CEO of EOS imaging, said, “We are fortunate to work with some of the best talent in spine surgery as we continue to make advancements to the EOS platform. It was exciting to see how leading spine surgeons embrace the capabilities of the spineEOS 3D planning solution and examples of where the software was a critical part of making the right treatment decision. We are proud and happy to contribute to the progress of the quality of spine surgery with simulation and planning that takes into account the full 3D anatomy of the patient.”

For more information, please visit www.eos-imaging.com.

EOS imaging has been chosen to be included in the new EnterNext© PEA-PME 150 index, composed of 150 French companies and listed on Euronext and Alternext markets in Paris.

EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI

About EOS imaging

EOS imaging designs, develops, and markets EOS®, an innovative medical imaging system dedicated to osteoarticular pathologies and orthopedics, as well as associated solutions. The Company is authorized to market in 51 countries, including the United States, Japan, China, and the European Union. The Group posted 2015 revenues of €21.8 million and employs 122 people. The Group is based in Paris and has five subsidiaries in Besançon (France), Cambridge (Massachusetts), Montreal (Canada), Frankfurt (Germany) and Singapore.

Next press release: 2016 Third-quarter sales: Thursday October 27, 2016 (after market close)

View source version on businesswire.com: http://www.businesswire.com/news/home/20160922006006/en/

(c)Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.